| |
[SORT BY TITLE] [SORT BY DATE] [SORT BY AUTHOR]
Value of Medicine
- Causing More Harm than Good: Conflict-of-Interest Rules Thwart Medical Progress By Richard A. Epstein, Forbes.com, 10-26-10
- Forest Laboratories and the Facts By Diana Furchtgott-Roth, RealClearMarkets, 05-05-11
- The Right Way to Stop Superbugs By David Gratzer, New York Post, 11-12-10
- Our Health Is Worsening At A Time When Medicine Has Never Been Better David Gratzer, Blog Post, 02-15-11
- How To Liberate New Frontier Of Modern American Medicine By Douglas Holtz-Eakin, Investor's Business Daily, 11-09-11
- FDA Is Slowing Down Necessary Drugs and Treatments By Paul Howard, Washington Examiner, 06-17-10
- Cancer Revolution Is Possible With More Flexible FDA By Paul Howard, Washington Examiner, 06-09-11
- The End of the Age of Lipitor? You'd Better Hope Not. By Paul Howard, Medical Progress Today, 11-30-11
- How To Wreck a Prescription-Drug Program By Paul Howard, Washington Times, 07-22-11
- A Double Edged Sword for U.S. Healthcare By Paul Howard, RealClearMarkets, 12-22-10
- Former Obama Adviser Warns of the Perils of Price Controls By Paul Howard, National Review Online, 08-17-11
- A Question for Doctor Berwick By Paul Howard, National Review Online, 08-24-10
- Gates Invests Time, Cash Into Drug Research By Paul Howard, Washington Examiner, 11-25-11
- High-Priced Cancer Drugs: Are They Worth It? By Paul Howard, National Review Online, 07-08-11
- Innovation, Not Spending Cuts, Improves Health Care By Paul Howard, Investor's Business Daily, 01-04-12
- Paul Howard interviews Marc M. Boutin, about PEDUFA and why the FDA needs to re-evaluate the way it approves drugs and medical devices. Paul Howard, Podcast: Interview, July 21, 2011
- The FDA and Methuselah By Peter W. Huber, Forbes.com, 04-12-10
- The Blue Pill Or The Red Pill? By Tomas J. Philipson, Forbes.com, 01-14-10
- How Obamacare Harms the Poor By Avik Roy, National Review Online, 07-30-12
|
|
|
